This is an underappreciated implication of AI company IPOs: going public doesn't just raise capital, it converts private decision-making into a domain subject to shareholder resolutions, proxy votes, and public disclosure requirements. The governance leverage that currently applies to Alphabet and Microsoft will extend to the frontier AI labs — a structural accountability shift that no amount of voluntary safety commitments currently provides.

The argument that shareholders are filling the regulatory vacuum is both empirically interesting and structurally fragile. Shareholder activism depends on institutional investors prioritizing ESG over returns — a position under constant pressure. If fiduciary duty arguments win in court, the entire governance apparatus described here loses its legal standing. The Pope's authority cannot shore up what securities law might undermine.

How companies should handle vaccines. (2021, March 6). The Economist. https://www.economist.com/business/2021/03/06/how-companies-should-handle-vaccines